Pura Vida Investments is a company that focuses on providing investment services and solutions. The company emphasizes sustainable and impact investing, aiming to generate positive social and environmental outcomes alongside financial returns.

Efrem Kamen

Frank Litvack

Pura Vida Investments

Pura Vida is a healthcare-focused hedge fund with a market-neutral approach, investing across the healthcare space, including medical technology and devices, biotechnology, pharmaceuticals, and healthcare services.

Acutus Medical

Field Trip Health

Greenlight Biosciences

Science 37

ATAI Life Sciences

Sensei Biotherapeutics

SLANG Worldwide

Solid Biosciences

Sonendo

DarioHealth

Lyra Therapeutics

MedAvail

Motus GI

NeoGenomics

Metric
Company Name	Pura Vida Investments
Symbol
MSH ID	COM:PURAVIDAINVESTMENTS
Market	PRIVATE
Sector	Financial Services & Finance
Industry	Investment Services
Country	US
Stage
Employee Count	11
Website	puravidainvestments.com
LinkedIn	pura-vida-investments
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:PURAVIDAINVESTMENTS

Pura Vida Investments

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue